Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00291044 · ClinicalTrials.gov registry record
HSV Seroprevalence and Diagnosis of Genital Herpes in Pregnant Women
A clinical trial, sponsored by Stony Brook University.
- Completed
- Registry status
- 300
- Enrollment target
NCT00291044: Completed study, sponsored by Stony Brook University.
NCT00291044 is a clinical trial that has completed, run by Stony Brook University. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00291044 has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
Brief summary: The current management guidelines recommended by ACOG rely on history as a screening method to determine pregnant women who are at risk for transmitting herpes to their newborn. History fails completely in identifying the women most at risk of transmitting herpes to their newborn - the seronegative woman who acquires a primary infection from her partner during pregnancy. Despite recent advances, both pregnant women and newborns continue to be at risk of acquiring herpes infection. Genital herpes infections are epidemic in the United States. In the early 1990's, 25% of women in the US were seropositive for the HSV-2 antibody. These numbers are likely higher now. The incidence of neonatal herpes in the US cannot be accurately estimated since it is not a reportable disease. However, in some areas of the US, the incidence is 1 in 3,200 live births which would translate to an incidence of approximately three infants a day in the US . In other areas of the US, the incidence is even higher, approaching 1 in 1,500 liveborns. This protocol examines patient acceptance of HSV-1 and HSV-2 type specific serologic testing and assesses patient counseling tools. In addition, seroprevalence of HSV-2 in pregnant patients will be collected and evaluated.
Interventions
- OTHER testing for HSV 1 and 2 IgG type specific antibosy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2005-09 |
| Est. Completion | 2009-09 |
What the finished NCT00291044 record still lists
NCT00291044 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which testing for HSV 1 and 2 IgG type specific antibosy is the first listed.
NCT00291044 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00291044 about?
NCT00291044 is a clinical study titled "HSV Seroprevalence and Diagnosis of Genital Herpes in Pregnant Women". Brief summary: The current management guidelines recommended by ACOG rely on history as a screening method to determine pregnant women who are at risk for transmitting herpes to their newborn. History fails completely in identifying the women most at risk of transmitting herpes to their newborn - th...
What is the current status of trial NCT00291044?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2005-09. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00291044?
The interventions under investigation include: testing for HSV 1 and 2 IgG type specific antibosy (OTHER).
Who is sponsoring clinical trial NCT00291044?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia